public protein databases Search Results


90
Prolexys Pharmaceuticals human yeast two-hybrid protein interaction network database
Human Yeast Two Hybrid Protein Interaction Network Database, supplied by Prolexys Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human yeast two-hybrid protein interaction network database/product/Prolexys Pharmaceuticals
Average 90 stars, based on 1 article reviews
human yeast two-hybrid protein interaction network database - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
InterPro Inc public protein databases
Public Protein Databases, supplied by InterPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/public protein databases/product/InterPro Inc
Average 90 stars, based on 1 article reviews
public protein databases - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Biognosys irt peptides fasta
Irt Peptides Fasta, supplied by Biognosys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/irt peptides fasta/product/Biognosys
Average 90 stars, based on 1 article reviews
irt peptides fasta - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Biotechnology Information public, non-redundant protein database
Public, Non Redundant Protein Database, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/public, non-redundant protein database/product/Biotechnology Information
Average 90 stars, based on 1 article reviews
public, non-redundant protein database - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Biotechnology Information genbank database
Genbank Database, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genbank database/product/Biotechnology Information
Average 90 stars, based on 1 article reviews
genbank database - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Human Protein Atlas immunohistochemistry-based expression data
Immunohistochemistry Based Expression Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immunohistochemistry-based expression data/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
immunohistochemistry-based expression data - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Biotechnology Information blast program
Blast Program, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/blast program/product/Biotechnology Information
Average 90 stars, based on 1 article reviews
blast program - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Human Protein Atlas immunohistochemistry database
Immunohistochemistry Database, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immunohistochemistry database/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
immunohistochemistry database - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
10X Genomics 10 x genomics
10 X Genomics, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/10 x genomics/product/10X Genomics
Average 90 stars, based on 1 article reviews
10 x genomics - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Human Protein Atlas adgb mrna
( A ) Representative overview of transcription factor impact on <t>ADGB</t> promoter-driven luciferase activity. Results are displayed in relative luminescence units (RLU) as ratio of firefly to Renilla luciferase activities. ( B ) Confirmation of overexpression of transcription factors. We performed qPCR analysis to assess expression intensity of all factors following transfection. RNA samples were DNase-treated before synthesis of cDNA to reduce vector contamination. Results are displayed as relative <t>mRNA</t> expression in fold change. The white bar shows the negative control; black bar shows FOXJ1 as positive control. MYBL2 and PITX2 are highlighted in blue. * p < 0.05, ** p < 0.01, **** p < 0.0001.
Adgb Mrna, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adgb mrna/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
adgb mrna - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Biotechnology Information genbank
( A ) Representative overview of transcription factor impact on <t>ADGB</t> promoter-driven luciferase activity. Results are displayed in relative luminescence units (RLU) as ratio of firefly to Renilla luciferase activities. ( B ) Confirmation of overexpression of transcription factors. We performed qPCR analysis to assess expression intensity of all factors following transfection. RNA samples were DNase-treated before synthesis of cDNA to reduce vector contamination. Results are displayed as relative <t>mRNA</t> expression in fold change. The white bar shows the negative control; black bar shows FOXJ1 as positive control. MYBL2 and PITX2 are highlighted in blue. * p < 0.05, ** p < 0.01, **** p < 0.0001.
Genbank, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genbank/product/Biotechnology Information
Average 90 stars, based on 1 article reviews
genbank - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Human Protein Atlas human protein atlas (hpa)
( A ) Representative overview of transcription factor impact on <t>ADGB</t> promoter-driven luciferase activity. Results are displayed in relative luminescence units (RLU) as ratio of firefly to Renilla luciferase activities. ( B ) Confirmation of overexpression of transcription factors. We performed qPCR analysis to assess expression intensity of all factors following transfection. RNA samples were DNase-treated before synthesis of cDNA to reduce vector contamination. Results are displayed as relative <t>mRNA</t> expression in fold change. The white bar shows the negative control; black bar shows FOXJ1 as positive control. MYBL2 and PITX2 are highlighted in blue. * p < 0.05, ** p < 0.01, **** p < 0.0001.
Human Protein Atlas (Hpa), supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human protein atlas (hpa)/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
human protein atlas (hpa) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


( A ) Representative overview of transcription factor impact on ADGB promoter-driven luciferase activity. Results are displayed in relative luminescence units (RLU) as ratio of firefly to Renilla luciferase activities. ( B ) Confirmation of overexpression of transcription factors. We performed qPCR analysis to assess expression intensity of all factors following transfection. RNA samples were DNase-treated before synthesis of cDNA to reduce vector contamination. Results are displayed as relative mRNA expression in fold change. The white bar shows the negative control; black bar shows FOXJ1 as positive control. MYBL2 and PITX2 are highlighted in blue. * p < 0.05, ** p < 0.01, **** p < 0.0001.

Journal: Cells

Article Title: Ectopic MYBL2-Mediated Regulation of Androglobin Gene Expression

doi: 10.3390/cells13100826

Figure Lengend Snippet: ( A ) Representative overview of transcription factor impact on ADGB promoter-driven luciferase activity. Results are displayed in relative luminescence units (RLU) as ratio of firefly to Renilla luciferase activities. ( B ) Confirmation of overexpression of transcription factors. We performed qPCR analysis to assess expression intensity of all factors following transfection. RNA samples were DNase-treated before synthesis of cDNA to reduce vector contamination. Results are displayed as relative mRNA expression in fold change. The white bar shows the negative control; black bar shows FOXJ1 as positive control. MYBL2 and PITX2 are highlighted in blue. * p < 0.05, ** p < 0.01, **** p < 0.0001.

Article Snippet: In the public databases of the human protein atlas, evidence exists for an occurrence of ADGB mRNA in myeloid dendritic cells derived from this lineage ( https://www.proteinatlas.org/ENSG00000118492-ADGB/immune+cell ; [ ]).

Techniques: Luciferase, Activity Assay, Over Expression, Expressing, Transfection, Plasmid Preparation, Negative Control, Positive Control

MYBL2 increases promoter activity in the upstream region close to the ADGB transcriptional start site (TSS). Luciferase reporter gene assays in HEK293T cells transfected with empty pGL3b vector or various ADGB promoter fragments with and without co-overexpression of MYBL2. ( A ) Schematic fragmentation of the ADGB promoter. The ADGB promoter was systematically fragmented into non-overlapping promoter segments. ( B ) Luciferase reporter gene assay on ADGB promoter (AP) fragments in three different lengths: AP431 (−1 bp to −431 bp), AP1032 (−432 bp to −1032 bp), and AP1981 (−1033 bp to −1981 bp) upstream of the ADGB TSS. ( C ) Luciferase reporter gene assay on AP sub-fragments of AP431 in three different lengths: AP431_A (−431 bp to −237 bp), AP431_B (−236 bp to −141 bp), and AP431_C (−140 bp to −1 bp). ( D ) Luciferase reporter gene assay on AP sub-fragments of AP431_C: AP431_C1 (−140 bp to −71 bp) and AP431_C2 (−70 bp to −1 bp). Results are displayed in relative luminescence units (RLU) as ratio of firefly to Renilla luciferase activities. Data are represented as means ± S.E.M; * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant).

Journal: Cells

Article Title: Ectopic MYBL2-Mediated Regulation of Androglobin Gene Expression

doi: 10.3390/cells13100826

Figure Lengend Snippet: MYBL2 increases promoter activity in the upstream region close to the ADGB transcriptional start site (TSS). Luciferase reporter gene assays in HEK293T cells transfected with empty pGL3b vector or various ADGB promoter fragments with and without co-overexpression of MYBL2. ( A ) Schematic fragmentation of the ADGB promoter. The ADGB promoter was systematically fragmented into non-overlapping promoter segments. ( B ) Luciferase reporter gene assay on ADGB promoter (AP) fragments in three different lengths: AP431 (−1 bp to −431 bp), AP1032 (−432 bp to −1032 bp), and AP1981 (−1033 bp to −1981 bp) upstream of the ADGB TSS. ( C ) Luciferase reporter gene assay on AP sub-fragments of AP431 in three different lengths: AP431_A (−431 bp to −237 bp), AP431_B (−236 bp to −141 bp), and AP431_C (−140 bp to −1 bp). ( D ) Luciferase reporter gene assay on AP sub-fragments of AP431_C: AP431_C1 (−140 bp to −71 bp) and AP431_C2 (−70 bp to −1 bp). Results are displayed in relative luminescence units (RLU) as ratio of firefly to Renilla luciferase activities. Data are represented as means ± S.E.M; * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant).

Article Snippet: In the public databases of the human protein atlas, evidence exists for an occurrence of ADGB mRNA in myeloid dendritic cells derived from this lineage ( https://www.proteinatlas.org/ENSG00000118492-ADGB/immune+cell ; [ ]).

Techniques: Activity Assay, Luciferase, Transfection, Plasmid Preparation, Over Expression, Reporter Gene Assay

PITX2 increases promoter activity in the upstream region close to the ADGB transcriptional start site (TSS). Luciferase reporter gene assays in HEK293T cells transfected with empty pGL3b vector or various ADGB promoter fragments with and without co-overexpression of PITX2. ( A ) Schematic fragmentation of the ADGB promoter. The ADGB promoter was systematically fragmented into non-overlapping promoter segments. ( B ) Luciferase reporter gene assay on ADGB promoter (AP) fragments in three different lengths: AP431 (−1 bp to −431 bp), AP1032 (−432 bp to −1032 bp), and AP1981 (−1033 bp to −1981 bp) upstream of the ADGB TSS. ( C ) Luciferase reporter gene assay on AP sub-fragments of AP431 in three different lengths: AP431_A (−431 bp to −237 bp), AP431_B (−236 bp to −141 bp), and AP431_C (−140 bp to −1 bp). ( D ) Luciferase reporter gene assay on AP sub fragments of AP431_C: AP431_C1 (−140 bp to −71 bp) and AP431_C2 (−70 bp to −1 bp). Results are displayed in relative luminescence units (RLU) as ratio of firefly to Renilla luciferase activities. Data are represented as means ± S.E.M; * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant).

Journal: Cells

Article Title: Ectopic MYBL2-Mediated Regulation of Androglobin Gene Expression

doi: 10.3390/cells13100826

Figure Lengend Snippet: PITX2 increases promoter activity in the upstream region close to the ADGB transcriptional start site (TSS). Luciferase reporter gene assays in HEK293T cells transfected with empty pGL3b vector or various ADGB promoter fragments with and without co-overexpression of PITX2. ( A ) Schematic fragmentation of the ADGB promoter. The ADGB promoter was systematically fragmented into non-overlapping promoter segments. ( B ) Luciferase reporter gene assay on ADGB promoter (AP) fragments in three different lengths: AP431 (−1 bp to −431 bp), AP1032 (−432 bp to −1032 bp), and AP1981 (−1033 bp to −1981 bp) upstream of the ADGB TSS. ( C ) Luciferase reporter gene assay on AP sub-fragments of AP431 in three different lengths: AP431_A (−431 bp to −237 bp), AP431_B (−236 bp to −141 bp), and AP431_C (−140 bp to −1 bp). ( D ) Luciferase reporter gene assay on AP sub fragments of AP431_C: AP431_C1 (−140 bp to −71 bp) and AP431_C2 (−70 bp to −1 bp). Results are displayed in relative luminescence units (RLU) as ratio of firefly to Renilla luciferase activities. Data are represented as means ± S.E.M; * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant).

Article Snippet: In the public databases of the human protein atlas, evidence exists for an occurrence of ADGB mRNA in myeloid dendritic cells derived from this lineage ( https://www.proteinatlas.org/ENSG00000118492-ADGB/immune+cell ; [ ]).

Techniques: Activity Assay, Luciferase, Transfection, Plasmid Preparation, Over Expression, Reporter Gene Assay

Schematic overview on dCas9-mediated interference strategy and mutation of AP431_C. Schematic overview of both experimental strategies (Variant A and B) to investigate potential MYBL2 binding sites on AP431_C. Variant A, CRISPR/dCas9 gRNAs (α, β, and γ) targeting specific regions on AP431_C (between −120 bp and −37 bp) were used to abolish MYBL2 binding to this region upstream of the ADGB TSS. gRNA α (−120 bp to −100 bp), gRNA β (−86 bp to −66 bp), and gRNA γ (−57 bp to −37 bp) are displayed in green and underlined. Variant B shows the locations of the used mutations on AP431_C (−100 bp to −40 bp upstream of the ADGB TSS). Substitution-based mutation at −96 to −92 bp (mut1), at −73 to −68 bp (mut2), −57 to −52 bp (mut3), and −51 to −46 bp (mut4), are highlighted in bold. For both variants, two evolutionarily conserved regions (Cons1 and Cons2) are highlighted with a grey background.

Journal: Cells

Article Title: Ectopic MYBL2-Mediated Regulation of Androglobin Gene Expression

doi: 10.3390/cells13100826

Figure Lengend Snippet: Schematic overview on dCas9-mediated interference strategy and mutation of AP431_C. Schematic overview of both experimental strategies (Variant A and B) to investigate potential MYBL2 binding sites on AP431_C. Variant A, CRISPR/dCas9 gRNAs (α, β, and γ) targeting specific regions on AP431_C (between −120 bp and −37 bp) were used to abolish MYBL2 binding to this region upstream of the ADGB TSS. gRNA α (−120 bp to −100 bp), gRNA β (−86 bp to −66 bp), and gRNA γ (−57 bp to −37 bp) are displayed in green and underlined. Variant B shows the locations of the used mutations on AP431_C (−100 bp to −40 bp upstream of the ADGB TSS). Substitution-based mutation at −96 to −92 bp (mut1), at −73 to −68 bp (mut2), −57 to −52 bp (mut3), and −51 to −46 bp (mut4), are highlighted in bold. For both variants, two evolutionarily conserved regions (Cons1 and Cons2) are highlighted with a grey background.

Article Snippet: In the public databases of the human protein atlas, evidence exists for an occurrence of ADGB mRNA in myeloid dendritic cells derived from this lineage ( https://www.proteinatlas.org/ENSG00000118492-ADGB/immune+cell ; [ ]).

Techniques: Mutagenesis, Variant Assay, Binding Assay, CRISPR

MYBL2-binding to the ADGB promoter is impaired by dCas9-mediated interference or mutation of the binding site. ( A ) Luciferase reporter gene assays in HEK293T cells transfected with empty pGL3b vector or AP431 with and without co-transfection of dCas9 and gRNAs (α, β, and γ) and with and without co-overexpression of MYBL2. The gRNA binding sites and conserved sequences are schematically depicted on top. ( B ) Luciferase reporter gene assays in HEK293T cells transfected with empty pGL3b vector or mutated AP431_C with and without co-overexpression of MYBL2. The position of the different mutations and the conserved sites are schematically depicted on top. Results are displayed in relative luminescence units (RLU) as ratio of firefly to Renilla luciferase activities. All statistically significant comparisons are shown. Data are represented as means ± S.E.M; ** p < 0.01, *** p < 0.001, ns = not significant).

Journal: Cells

Article Title: Ectopic MYBL2-Mediated Regulation of Androglobin Gene Expression

doi: 10.3390/cells13100826

Figure Lengend Snippet: MYBL2-binding to the ADGB promoter is impaired by dCas9-mediated interference or mutation of the binding site. ( A ) Luciferase reporter gene assays in HEK293T cells transfected with empty pGL3b vector or AP431 with and without co-transfection of dCas9 and gRNAs (α, β, and γ) and with and without co-overexpression of MYBL2. The gRNA binding sites and conserved sequences are schematically depicted on top. ( B ) Luciferase reporter gene assays in HEK293T cells transfected with empty pGL3b vector or mutated AP431_C with and without co-overexpression of MYBL2. The position of the different mutations and the conserved sites are schematically depicted on top. Results are displayed in relative luminescence units (RLU) as ratio of firefly to Renilla luciferase activities. All statistically significant comparisons are shown. Data are represented as means ± S.E.M; ** p < 0.01, *** p < 0.001, ns = not significant).

Article Snippet: In the public databases of the human protein atlas, evidence exists for an occurrence of ADGB mRNA in myeloid dendritic cells derived from this lineage ( https://www.proteinatlas.org/ENSG00000118492-ADGB/immune+cell ; [ ]).

Techniques: Binding Assay, Mutagenesis, Luciferase, Transfection, Plasmid Preparation, Cotransfection, Over Expression

MYBL2 ( left panel) and PITX2 ( right panel) interact with the endogenous ADGB promoter via direct binding. ( A ) Chromatin immunoprecipitation (ChIP) experiments in HEK293T cells transiently transfected with MYBL2 or FLAG-PITX2. Coprecipitated chromatin derived from the ADGB promoter was determined by qPCR using a primer pair covering +21 bp to −184 bp upstream of the ADGB TSS. Control regions were targeted upstream (5′ end, ADGB 5′) and downstream (3′ end, ADGB 3′) of ADGB on chromosome 6 and two independent AURKA loci (as positive and negative control). Due to the high differences in intensity, statistics for both loci were conducted separately. ( B ) Relative mRNA expression of endogenous ADGB following transient overexpression of MYBL2 or PITX2 compared to empty vector in A375 cells or HEK293T cells. ( C ) Overexpression of MYBL2 ( left panel) and PITX2 ( right panel) was verified by immunoblotting using specific antibodies against MYBL2 and PITX2. Data are represented as means ± S.E.M; * p < 0.05, ** p < 0.01).

Journal: Cells

Article Title: Ectopic MYBL2-Mediated Regulation of Androglobin Gene Expression

doi: 10.3390/cells13100826

Figure Lengend Snippet: MYBL2 ( left panel) and PITX2 ( right panel) interact with the endogenous ADGB promoter via direct binding. ( A ) Chromatin immunoprecipitation (ChIP) experiments in HEK293T cells transiently transfected with MYBL2 or FLAG-PITX2. Coprecipitated chromatin derived from the ADGB promoter was determined by qPCR using a primer pair covering +21 bp to −184 bp upstream of the ADGB TSS. Control regions were targeted upstream (5′ end, ADGB 5′) and downstream (3′ end, ADGB 3′) of ADGB on chromosome 6 and two independent AURKA loci (as positive and negative control). Due to the high differences in intensity, statistics for both loci were conducted separately. ( B ) Relative mRNA expression of endogenous ADGB following transient overexpression of MYBL2 or PITX2 compared to empty vector in A375 cells or HEK293T cells. ( C ) Overexpression of MYBL2 ( left panel) and PITX2 ( right panel) was verified by immunoblotting using specific antibodies against MYBL2 and PITX2. Data are represented as means ± S.E.M; * p < 0.05, ** p < 0.01).

Article Snippet: In the public databases of the human protein atlas, evidence exists for an occurrence of ADGB mRNA in myeloid dendritic cells derived from this lineage ( https://www.proteinatlas.org/ENSG00000118492-ADGB/immune+cell ; [ ]).

Techniques: Binding Assay, Chromatin Immunoprecipitation, Transfection, Derivative Assay, Control, Negative Control, Expressing, Over Expression, Plasmid Preparation, Western Blot